149366-37-0 Usage
Uses
Used in Pharmaceutical Industry:
6,7-Dichloro-3-styryl-quinoxalin-2-ol is used as a potential therapeutic agent for its anti-inflammatory properties, which can help in the treatment of inflammatory diseases and conditions.
6,7-Dichloro-3-styryl-quinoxalin-2-ol is used as an anti-tumor agent for its potential to inhibit the growth and progression of cancer cells, making it a candidate for further research in oncology.
6,7-Dichloro-3-styryl-quinoxalin-2-ol is used as an anti-malarial agent due to its potential to combat malaria-causing parasites, offering a new avenue for the development of anti-malarial drugs.
Used in Neuroprotective Applications:
6,7-Dichloro-3-styryl-quinoxalin-2-ol is used as a neuroprotective agent for its potential to protect neurons from damage and degeneration, which can be beneficial in the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's.
Used in Antioxidant Applications:
6,7-Dichloro-3-styryl-quinoxalin-2-ol is used as an antioxidant agent for its ability to neutralize harmful free radicals, which can help in preventing oxidative stress and related health issues.
Check Digit Verification of cas no
The CAS Registry Mumber 149366-37-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,3,6 and 6 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 149366-37:
(8*1)+(7*4)+(6*9)+(5*3)+(4*6)+(3*6)+(2*3)+(1*7)=160
160 % 10 = 0
So 149366-37-0 is a valid CAS Registry Number.
149366-37-0Relevant articles and documents
Styryl-containing quinoxalinone derivatives and preparation method thereof
-
Paragraph 0014-0017, (2020/09/30)
The invention belongs to the technical field of medicinal chemistry, and particularly relates to styryl-containing quinoxalinone derivatives and a preparation method thereof, and the structure of thesynthesized compound is shown as the following formula I
A novel synthesis of 2-(2-quinoxalino)-3,5-diarylfurans
Duffy, Kevin J.,Haltiwanger, R. Curtius,Huang, Yifang,Konialian-Beck, Arda,Luengo, Juan I.
, p. 8017 - 8020 (2007/10/03)
A short synthesis of 2-(2-quinoxalino)-3,5-diarylfurans, allowing the stepwise introduction of the aromatic rings, is designed and implemented utilizing the DDQ promoted cyclization of 4-(2-quinoxalino)-1,3- diarylbutanones as the key transformation.